㰀栀琀洀氀㸀 
㰀氀椀渀欀 爀攀氀㴀∀猀琀礀氀攀猀栀攀攀琀∀ 琀礀瀀攀㴀∀琀攀砀琀⼀挀猀猀∀ 栀爀攀昀㴀∀猀琀礀氀攀⸀挀猀猀∀⼀㸀 
㰀戀漀搀礀㸀 
Centre de Référence des Rhumatismes Inflammatoires et Maladies Autoimmunes Systémiques Rares de l’Enfant (RAISE) / 2017 
 
60 
Rapport 
de 
l’OMS-Europe, 
publié 
Education 
Programmes 
traduit 
en français en 1998. Recommandations de la Société 
Française 
de 
polyarthrite 
Gaujoux-Vial 
rhumatoïde. 
C, 
Gossec 
du 
Rhumatisme 81 (2014) 303-312. Épidémiologie et présentation 
clinique 
Behrens 
EM, 
Beukelman 
T, 
Gallo L, Spangler J, Rosenkranz M, 
Arkachaisri 
T, 
et 
al. 
Evaluation of the presentation of systemic 
onset 
the 
Pennsylvania 
Systemic 
Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol. 2008 Feb;35(2):343–8.  Saurenmann 
RK, 
Rose 
RM, 
et 
idiopathic 
in 
a 
multiethnic cohort: ethnicity as a risk 
Arthritis 
Rheum. 
2007 Jun;56(6):1974–84.  Évaluation des traitements 
Filocamo 
Sztajnbok 
F, 
A, 
et 
al. 
Development 
simple 
measure 
of 
arthritis. 
Arthritis 
Rheum. 
2007 Aug 15;57(6):913–20.  
Gartlehner 
KN. 
Biologics 
for 
treatment 
idiopathic 
of 
arthritis: 
a 
systematic review and critical analysis of the evidence. Clin Rheumatol. 
Jan;27(1):67–76.  
2008 
Lurati 
B, 
Desiati 
Gattinara comparison criteria therapeutic patients idiopathic Gerloni 
et 
response 
in 
juvenile treated 
and/or 
factor 
Arthritis 2006 
with 
arthritis 
methotrexate with 
anti-tumor 
alpha 
Rheum. 
May;54(5):1602–7.  
Palmisani E, Solari N, Magni- 
Manzoni 
E, 
Panigada 
S, 
et 
juvenile 
idiopathic arthritis activity and damage disease. 
Arthritis 
Rheum. 
2006 Dec 15;55(6):843–9.  Pouchot 
Lemelle 
Validation 
of 
the 
Health 
Questionnaire 
Assessment 
(CHAQ) 
Joint 
Bone 
2002 
Wallace 
CA, 
Ruperto 
N,